Hepatocellular Carcinoma (HCC) – Richard Finn, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Hepatocellular Carcinoma (HCC) – Richard Finn, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Wednesday February 13, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Richard Finn, MD, Professor of Medicine at the Geffen School of Medicine, UCLA, discuss hepatocellular carcinoma (HCC) clinical highlights from ASCO GI 2019

Featured Videos

Arndt Vogel, MD, elaborates on some of the key takeaways from the GO30140 trial

Shirish M. Gadgeel MBBS, speculates on the future of RET-altered NSCLC

Dennis J. Slamon, MD, PhD, on the significance of the phase III MONALEESA-3 trial